This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2006-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Beerse, BE (2006)
- Brasschaat, BE (2006 - 2012)
Company Filing History:
Years Active: 2006-2012
Title: The Innovations of Stefan Leo Jozef Masure
Introduction
Stefan Leo Jozef Masure is a notable inventor based in Brasschaat, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of neurotrophic growth factors. With a total of 4 patents to his name, Masure's work has the potential to impact various medical applications.
Latest Patents
Masure's latest patents include groundbreaking research on neurotrophic growth factors. One of his patents discloses an isolated nucleic acid molecule encoding a human neurotrophic growth factor designated enovin. This growth factor has a specific amino acid sequence and can be used to transform host cells, tissues, or organisms by including it in an appropriate vector. Another patent also focuses on an isolated nucleic acid molecule encoding the same neurotrophic growth factor, emphasizing its potential for medical advancements.
Career Highlights
Stefan Masure is currently associated with Janssen Pharmaceutica NV, a leading pharmaceutical company. His work at Janssen has allowed him to explore innovative solutions in the field of biotechnology. Masure's research is pivotal in understanding and developing treatments that utilize neurotrophic growth factors.
Collaborations
Masure has collaborated with notable colleagues such as Alan Richardson and Hugo Alfonso Geerts. These collaborations have further enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Stefan Leo Jozef Masure is a prominent inventor whose work in neurotrophic growth factors showcases his dedication to advancing biotechnology. His patents reflect a commitment to innovation that could lead to significant medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
